Expert Review of Cardiovascular Therapy最新文献_第6页

Why selective screening for asymptomatic carotid stenosis is currently appropriate: a special report. 为什么目前适合对无症状颈动脉狭窄进行选择性筛查：特别报告。

IF 1.8

Expert Review of Cardiovascular Therapy Pub Date : 2024-04-01 Epub Date: 2024-03-18 DOI: 10.1080/14779072.2024.2330660

Kosmas I Paraskevas, Alan Dardik, Marc L Schermerhorn, Christos D Liapis, Armando Mansilha, Brajesh K Lal, William A Gray, Martin M Brown, Piotr Myrcha, Carl J Lavie, Clark J Zeebregts, Eric A Secemsky, Luca Saba, Matthew Blecha, Victor Gurevich, Mauro Silvestrini, Ales Blinc, Alexei Svetlikov, Jose Fernandes E Fernandes, Peter A Schneider, Peter Gloviczki, Christopher J White, Ali F AbuRahma

{"title":"Why selective screening for asymptomatic carotid stenosis is currently appropriate: a special report.","authors":"Kosmas I Paraskevas, Alan Dardik, Marc L Schermerhorn, Christos D Liapis, Armando Mansilha, Brajesh K Lal, William A Gray, Martin M Brown, Piotr Myrcha, Carl J Lavie, Clark J Zeebregts, Eric A Secemsky, Luca Saba, Matthew Blecha, Victor Gurevich, Mauro Silvestrini, Ales Blinc, Alexei Svetlikov, Jose Fernandes E Fernandes, Peter A Schneider, Peter Gloviczki, Christopher J White, Ali F AbuRahma","doi":"10.1080/14779072.2024.2330660","DOIUrl":"10.1080/14779072.2024.2330660","url":null,"abstract":"Introduction: Two of the main reasons recent guidelines do not recommend routine population-wide screening programs for asymptomatic carotid artery stenosis (AsxCS) is that screening could lead to an increase of carotid revascularization procedures and that such mass screening programs may not be cost-effective. Nevertheless, selective screening for AsxCS could have several benefits. This article presents the rationale for such a program.Areas covered: The benefits of selective screening for AsxCS include early recognition of AsxCS allowing timely initiation of preventive measures to reduce future myocardial infarction (MI), stroke, cardiac death and cardiovascular (CV) event rates.Expert opinion: Mass screening programs for AsxCS are neither clinically effective nor cost-effective. Nevertheless, targeted screening of populations at high risk for AsxCS provides an opportunity to identify these individuals earlier rather than later and to initiate a number of lifestyle measures, risk factor modifications, and intensive medical therapy in order to prevent future strokes and CV events. For patients at 'higher risk of stroke' on best medical treatment, a prophylactic carotid intervention may be considered.","PeriodicalId":12098,"journal":{"name":"Expert Review of Cardiovascular Therapy","volume":" ","pages":"159-165"},"PeriodicalIF":1.8,"publicationDate":"2024-04-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"140119190","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

引用次数: 0

Aveir VR leadless pacemaker: interview with professor Tom Wong. Aveir VR 无导线起搏器：Tom Wong 教授访谈。

IF 2

Expert Review of Cardiovascular Therapy Pub Date : 2024-04-01 Epub Date: 2024-05-09 DOI: 10.1080/14779072.2024.2340260

Tom Wong

引用次数: 0

How will coronary physiology, plaque vulnerability and ischemia be integrated in future patient pathways with chest pain? 如何将冠状动脉生理学、斑块易损性和缺血纳入未来胸痛患者的治疗路径？

IF 2

Expert Review of Cardiovascular Therapy Pub Date : 2024-04-01 Epub Date: 2024-04-28 DOI: 10.1080/14779072.2024.2347224

Richard J Jabbour, Nick Curzen

引用次数: 0

Angiographic patterns in spontaneous coronary artery dissection: novel diagnostic insights. 自发性冠状动脉夹层的血管造影模式：新的诊断见解。

IF 2

Expert Review of Cardiovascular Therapy Pub Date : 2024-04-01 Epub Date: 2024-05-02 DOI: 10.1080/14779072.2024.2349103

Marcos García-Guimarães, Teresa Bastante, David Del Val, Diego Fernández-Rodríguez, Teresa Guiberteau-Diaz, Jorge Salamanca, Fernando Rivero, Fernando Alfonso

引用次数: 0

Sex differences in trends and in-hospital outcomes of acute myocardial infarction in patients with familial hypercholesterolemia: insights from a large national database. 家族性高胆固醇血症患者急性心肌梗死的趋势和院内预后的性别差异：大型国家数据库的启示。

IF 2

Expert Review of Cardiovascular Therapy Pub Date : 2024-04-01 Epub Date: 2024-03-12 DOI: 10.1080/14779072.2024.2329720

Frederick Berro Rivera, Sung Whoy Cha, Mara Bernadette Liston, Sonny Redula, Nathan Ross B Bantayan, Nishant Shah, Mamas A Mamas, Annabelle Santos Volgman

{"title":"Sex differences in trends and in-hospital outcomes of acute myocardial infarction in patients with familial hypercholesterolemia: insights from a large national database.","authors":"Frederick Berro Rivera, Sung Whoy Cha, Mara Bernadette Liston, Sonny Redula, Nathan Ross B Bantayan, Nishant Shah, Mamas A Mamas, Annabelle Santos Volgman","doi":"10.1080/14779072.2024.2329720","DOIUrl":"10.1080/14779072.2024.2329720","url":null,"abstract":"Background: Sex differences in clinical outcomes following acute myocardial infarction (AMI) are well known. However, data on sex differences among patients with familial hypercholesterolemia (FH) are limited. We aimed to explore sex differences in outcomes of AMI among patients with FH from a national administrative dataset.Research design and methods: We utilized the National Inpatient Sample to identify admissions with a primary diagnosis of AMI and a secondary diagnosis of FH. Our primary outcome of interest was in-hospital mortality; secondary outcomes were performance of percutaneous coronary intervention (PCI), coronary artery bypass grafting (CABG), respiratory complications, use of inotropes, use of mechanical circulatory support (MCS), bleeding complications, transfusion and facility discharge. We adjusted for demographics (model A), comorbidities (model B), and intervention (model C).Results: Between October 2016 and December 2020, 5,714,993 admissions with a primary diagnosis of AMI were identified, of which 3,035 (0.05%) had a secondary diagnosis of FH. In-hospital mortality did not differ between men and women (Model C, adjusted OR = 0.85; 95% CI 0.28-2.60, p = 0.773). There was no sex difference in the secondary outcomes.Conclusion: Despite generally being older and having more comorbidities, women with FH fair equally with men with FH in terms of mortality during AMI admission.","PeriodicalId":12098,"journal":{"name":"Expert Review of Cardiovascular Therapy","volume":" ","pages":"193-200"},"PeriodicalIF":2.0,"publicationDate":"2024-04-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"140068287","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

引用次数: 0

Pulmonary vascular disease and optical coherence tomography imaging in patients with Fontan palliation. 丰坦姑息治疗患者的肺血管疾病和光学相干断层成像。

IF 2

Expert Review of Cardiovascular Therapy Pub Date : 2024-04-01 Epub Date: 2024-03-25 DOI: 10.1080/14779072.2024.2330657

Marie-A Chaix, Réda Ibrahim, Jean-Claude Tardif, Colombe Roy, François-Pierre Mongeon, Annie Dore, Blandine Mondésert, Paul Khairy

{"title":"Pulmonary vascular disease and optical coherence tomography imaging in patients with Fontan palliation.","authors":"Marie-A Chaix, Réda Ibrahim, Jean-Claude Tardif, Colombe Roy, François-Pierre Mongeon, Annie Dore, Blandine Mondésert, Paul Khairy","doi":"10.1080/14779072.2024.2330657","DOIUrl":"10.1080/14779072.2024.2330657","url":null,"abstract":"Introduction: The Fontan procedure is the palliative procedure of choice for patients with single ventricle physiology. Pulmonary vascular disease (PVD) is an important contributor to Fontan circulatory failure.Areas covered: We review the pathophysiology of PVD in patients with Fontan palliation and share our initial experience with optical coherence tomography (OCT) in supplementing standard hemodynamics in characterizing Fontan-associated PVD. In the absence of a sub-pulmonary ventricle, low pulmonary vascular resistance (PVR; ≤2 WU/m2) is required to sustain optimal pulmonary blood flow. PVD is associated with adverse pulmonary artery (PA) remodeling resulting from the non-pulsatile low-shear low-flow circulation. Predisposing factors to PVD include impaired PA growth, endothelial dysfunction, hypercoagulable state, and increased ventricular end-diastolic pressure. OCT parameters that show promise in characterizing Fontan-associated PVD include the PA intima-to-media ratio and wall area ratio (i.e. difference between the whole-vessel area and the luminal area divided by the whole-vessel area).Expert opinion: OCT carries potential in characterizing PVD in patients with Fontan palliation. PA remodeling is marked by intimal hyperplasia, with medial regression. Further studies are required to determine the role of OCT in informing management decisions and assessing therapeutic responses.","PeriodicalId":12098,"journal":{"name":"Expert Review of Cardiovascular Therapy","volume":" ","pages":"153-158"},"PeriodicalIF":2.0,"publicationDate":"2024-04-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"140109676","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

引用次数: 0

When to ablate in Brugada and early repolarization syndromes. 何时对 Brugada 和早期再极化综合征进行消融。

IF 2

Expert Review of Cardiovascular Therapy Pub Date : 2024-01-01 Epub Date: 2024-03-07 DOI: 10.1080/14779072.2024.2326549

Eloi Vacher, Jean Baptiste Gourraud, Vincent Probst

引用次数: 0

Should patients with diabetes be routinely screened for atrial fibrillation? 是否应对糖尿病患者进行心房颤动常规筛查？

IF 2

Expert Review of Cardiovascular Therapy Pub Date : 2024-01-01 Epub Date: 2024-03-10 DOI: 10.1080/14779072.2024.2328645

Prashant D Bhave, Elsayed Soliman

引用次数: 0

Risk factors modification in atrial fibrillation: a brief review. 心房颤动的风险因素调整：简要回顾。

IF 2

Expert Review of Cardiovascular Therapy Pub Date : 2024-01-01 Epub Date: 2023-12-18 DOI: 10.1080/14779072.2023.2294728

Sukhbir Randhawa, Subrat Da, Wilbert S Aronow

{"title":"Risk factors modification in atrial fibrillation: a brief review.","authors":"Sukhbir Randhawa, Subrat Da, Wilbert S Aronow","doi":"10.1080/14779072.2023.2294728","DOIUrl":"10.1080/14779072.2023.2294728","url":null,"abstract":"Introduction: Atrial fibrillation (AF) is a supraventricular arrhythmia characterized by fibrillatory waves in the atria with an irregular ventricular rhythm. It is the most common arrhythmia treated in clinical practice. AF is associated with approximately five-fold increase in risk of cerebrovascular accident (stroke) and two-fold increase in cognitive dysfunction and all-cause mortality.Areas covered: Multiple risk factors have been identified for development of AF including age, hypertension, diabetes, and obesity. Primary and secondary prevention strategies aimed at reducing the incidence of AF can have a dramatic clinical and economic impact. Multiple studies have shown that lifestyle interventions can reduce predisposing factors, reverse the pathophysiology behind AF, and decrease disease burden. In this brief review we aim at exploring the current state of knowledge regarding risk factor modifications that decrease incidence and prevalence of AF.Expert opinion: This is an evolving field of research and further studies to elucidate the magnitude of effect of these interventions as well as the pathophysiological mechanisms driving these effects are underway.","PeriodicalId":12098,"journal":{"name":"Expert Review of Cardiovascular Therapy","volume":" ","pages":"7-12"},"PeriodicalIF":2.0,"publicationDate":"2024-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"138801029","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

引用次数: 0

Original algorithms for the detection of cardiovascular involvement of neglected tropical diseases. 用于检测被忽视热带疾病心血管受累情况的原创算法。

IF 2

Expert Review of Cardiovascular Therapy Pub Date : 2024-01-01 Epub Date: 2024-02-26 DOI: 10.1080/14779072.2024.2315090

Kiera Liblik, Ioana Tereza Florica, Adrian Baranchuk

{"title":"Original algorithms for the detection of cardiovascular involvement of neglected tropical diseases.","authors":"Kiera Liblik, Ioana Tereza Florica, Adrian Baranchuk","doi":"10.1080/14779072.2024.2315090","DOIUrl":"10.1080/14779072.2024.2315090","url":null,"abstract":"Introduction: Neglected tropical diseases (NTDs) introduce considerable morbidity and mortality on a global scale, directly impacting over 1 billion individuals as well as their families and communities. Afflicted individuals may have limited access to resources and care in these regions, contributing to a high proportion of chronic, progressive, and systemic disease. The cardiovascular system is at particular risk of demise for several NTDs, yet remains largely unstudied due in part to the lack of robust data collection mechanisms in the most impacted regions.Areas covered: The present review is a part of the Neglected Tropical Diseases and other Infectious Diseases affecting the Heart (NET-Heart) Project, aiming at summarizing the current knowledge on cardiovascular implications of NTDs and providing diagnostic as well as management recommendations which can be tailored to low-resource settings. The diagnostic and management algorithms of 13 unique NTDs are presented and summarized.Expert opinion: Recognizing cardiac manifestations of NTDs can significantly alter disease trajectory and all physicians benefit from improved knowledge about NTDs. Great potential exists to advance patient care by improving data collection, communication, and international collaboration.","PeriodicalId":12098,"journal":{"name":"Expert Review of Cardiovascular Therapy","volume":" ","pages":"59-74"},"PeriodicalIF":2.0,"publicationDate":"2024-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"139680867","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

引用次数: 0